Shionogi & Co., Ltd. (OTCMKTS:SGIOY) Short Interest Down 27.8% in December

Shionogi & Co., Ltd. (OTCMKTS:SGIOY - Get Free Report) was the target of a large decline in short interest in December. As of December 31st, there was short interest totalling 139,000 shares, a decline of 27.8% from the December 15th total of 192,400 shares. Based on an average trading volume of 586,000 shares, the days-to-cover ratio is currently 0.2 days.

Shionogi & Co., Ltd. Stock Performance

Shares of OTCMKTS SGIOY traded up $0.10 during mid-day trading on Friday, hitting $7.12. 194,338 shares of the stock traded hands, compared to its average volume of 231,962. The stock has a fifty day moving average price of $6.97 and a 200-day moving average price of $8.75. The company has a market cap of $12.11 billion, a price-to-earnings ratio of 12.14, a PEG ratio of 4.78 and a beta of 0.21. Shionogi & Co., Ltd. has a 52 week low of $6.22 and a 52 week high of $9.11.

About Shionogi & Co., Ltd.

Shionogi & Co, Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Cabenuva and Apretude an anti-HIV and HIV prophylactic drug; Xocova an oral COVID-19 treatment drug; Finibax a carbapenem antibiotic; Xofluza, an influenza antiviral drug; and Tivicay, an anti-HIV drug.